Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril for prevention of diabetes, hypertension, and albuminuria in high-risk Tiwi Aboriginal adults
ACTRN12608000371392Phase 4Recruiting
- Sponsor
- The University of Queensland
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of perindopril in type 2 diabetes mellitus (T2DM), hypertension (HTN), albuminuria and 1 more, sponsored by The University of Queensland. Started Jun 2008; status: recruiting.
02
Drugs
perindopril
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)albuminuriachronic kidney disease (CKD)
Beyond the preview
Go deeper on ACTRN12608000371392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000371392.